Bottneuro
Early-stage diagnosis of Alzheimer’s disease.
Bottneuro has raised €4.2M across 2 funding rounds from 4 investors, most recently a round in Dec 2022. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandbottneuro.ch/wp ↗
Total raised
€4.2M
€4,200,092
Funding rounds
2
Investors
4
distinct backers
Active since
2021-12
latest 2022-12
Funding by year
EUR raised per yearBottneuro — funding by year — interactive chart.
Data table
| Bottneuro — funding by year | |
|---|---|
| 2021 | €144k |
| 2022 | €4.1M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-15 | Other | €4.1M | DART Labs Ventures,Hemex,Zühlke Ventures | View deal → |
| 2021-12-20 | Other | €144k | Venture Kick | View deal → |
Related news
- CHF 4 million for Bottneurostartupticker.ch · 2022-12
- CHF 150,000 to advance personalized therapies for Alzheimer’s diseasestartupticker.ch · 2021-12
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData